UB Paderborn / Katalog / Suche / in CDI

Investigating the effect of optimal cytoreduction in the context of platinum sensitivity in high‐grade serous ovarian cancer

Acta obstetricia et gynecologica Scandinavica, 2022-10, Vol.101 (10), p.1085-1092

2022

Link zum Volltext

Verfügbarkeit prüfen

Disparity of ovarian cancer survival between urban and rural settings

International journal of gynecological cancer, 2022-04, Vol.32 (4), p.540-546

2022

Link zum Volltext

Verfügbarkeit prüfen

Interval debulking surgery is not worth the wait: a National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy

International journal of gynecological cancer, 2020-06, Vol.30 (6), p.845-852

2020

Link zum Volltext

Verfügbarkeit prüfen

Creation and validation of models to predict response to primary treatment in serous ovarian cancer

Scientific reports, 2021-03, Vol.11 (1), p.5957-5957, Article 5957

2021

Link zum Volltext

Verfügbarkeit prüfen

Identifying novel ovarian tumor biomarkers through mining of the transcriptome of circulating immune cells: A proof‐of‐concept study

American journal of reproductive immunology (1989), 2021-10, Vol.86 (4), p.e13469-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Chemotherapeutic Response in Ovarian Cancers Using Publicly Available High-Throughput Data

Cancer research (Chicago, Ill.), 2014-07, Vol.74 (14), p.3902-3912

2014

Link zum Volltext

Verfügbarkeit prüfen

The impact of multi-modal therapy on survival for uterine carcinosarcomas

Gynecologic oncology, 2010-03, Vol.116 (3), p.419-423

2010

Link zum Volltext

Verfügbarkeit prüfen

Prediction of chemo-response in serous ovarian cancer

Molecular cancer, 2016-10, Vol.15 (1), p.66-66, Article 66

2016

Link zum Volltext

Verfügbarkeit prüfen

FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways

Clinical and translational medicine, 2023-05, Vol.13 (5), p.e1223-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables

International journal of molecular sciences, 2019-03, Vol.20 (5), p.1205

2019

Link zum Volltext

Verfügbarkeit prüfen

Association of Distance to Gynecologic Oncologist and Survival in a Rural Midwestern State

Women's health reports (New Rochelle, N.Y.), 2022-08, Vol.3 (1), p.678-685

2022

Link zum Volltext

Verfügbarkeit prüfen

Current Issues in the Management of Endometrial Cancer

Mayo Clinic proceedings, 2008, Vol.83 (1), p.97-112

2008

Link zum Volltext

Verfügbarkeit prüfen

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Molecular cancer, 2014-05, Vol.13 (1), p.129-129, Article 129

2014

Link zum Volltext

Verfügbarkeit prüfen

Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer

Gynecologic oncology, 2009-07, Vol.114 (1), p.3-11

2009

Link zum Volltext

Verfügbarkeit prüfen

Genomic characterization of five commonly used endometrial cancer cell lines

International journal of oncology, 2020-12, Vol.57 (6), p.1348-1357

2020

Link zum Volltext

Verfügbarkeit prüfen

Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes

Carcinogenesis (New York), 2010-05, Vol.31 (5), p.827-833

2010

Link zum Volltext

Verfügbarkeit prüfen

A nuclear polymorphism at the 8q24 region is associated with improved survival time and chemo‑response in high‑grade serous ovarian cancer

Oncology letters, 2021-10, Vol.22 (4), p.1, Article 733

2021

Link zum Volltext

Verfügbarkeit prüfen

Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence

International journal of molecular sciences, 2022-12, Vol.23 (24), p.16014

2022

Link zum Volltext

Verfügbarkeit prüfen

Identification of Novel lncRNAs in Ovarian Cancer and Their Impact on Overall Survival

International journal of molecular sciences, 2021-01, Vol.22 (3), p.1079

2021

Link zum Volltext

Verfügbarkeit prüfen

ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer

PloS one, 2022-12, Vol.17 (12), p.e0278408-e0278408

2022

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines

Gynecologic oncology, 2005-10, Vol.99 (1), p.135-141

2005

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Epithelial Ovarian Cancer Outcomes With Integration of Genomic Data

Clinical obstetrics and gynecology, 2020-03, Vol.63 (1), p.92

2020

Link zum Volltext

Verfügbarkeit prüfen

Patterns of inguinal groin metastases in squamous cell carcinoma of the vulva

Gynecologic oncology, 2007-06, Vol.105 (3), p.742-746

2007

Link zum Volltext

Verfügbarkeit prüfen

Microbial Communities in Gynecological Cancers and Their Association with Tumor Somatic Variation

Cancers, 2023-06, Vol.15 (13), p.3316

2023

Link zum Volltext

Verfügbarkeit prüfen

Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer

Cancers, 2022-07, Vol.14 (14), p.3554

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Investigating the effect of optimal cytoreduction in the context of platinum sensitivity in high‐grade serous ovarian cancer

Disparity of ovarian cancer survival between urban and rural settings

Interval debulking surgery is not worth the wait: a National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy

Creation and validation of models to predict response to primary treatment in serous ovarian cancer

Identifying novel ovarian tumor biomarkers through mining of the transcriptome of circulating immune cells: A proof‐of‐concept study

Analysis of Chemotherapeutic Response in Ovarian Cancers Using Publicly Available High-Throughput Data

The impact of multi-modal therapy on survival for uterine carcinosarcomas

Prediction of chemo-response in serous ovarian cancer

FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways

A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables

Association of Distance to Gynecologic Oncologist and Survival in a Rural Midwestern State

Current Issues in the Management of Endometrial Cancer

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer

Genomic characterization of five commonly used endometrial cancer cell lines

Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes

A nuclear polymorphism at the 8q24 region is associated with improved survival time and chemo‑response in high‑grade serous ovarian cancer

Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence

Identification of Novel lncRNAs in Ovarian Cancer and Their Impact on Overall Survival

ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer

Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines

Prediction of Epithelial Ovarian Cancer Outcomes With Integration of Genomic Data

Patterns of inguinal groin metastases in squamous cell carcinoma of the vulva

Microbial Communities in Gynecological Cancers and Their Association with Tumor Somatic Variation

Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer

Suchergebnisse filtern